Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 Oct;39(10):958–961. doi: 10.1136/jnnp.39.10.958

Levodopa and Huntington's chorea

C Loeb 1,2,1, G Roccatagliata 1,2, G La Medica 1,2, G Abbruzzese 1,2, C Albano 1,2
PMCID: PMC492498  PMID: 137301

Abstract

Two patients with Huntington's chorea are reported whose psychiatric and neurological symptoms greatly improved after treatment with L-dopa. In both cases the basal values of CSF HVA were markedly decreased, being increased by the treatment with L-dopa.

Full text

PDF
958

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aquilonius S. M., Sjöström R. Cholinergic and dopaminergic mechanisms in Huntington's chorea. Life Sci I. 1971 Apr 1;10(7):405–414. doi: 10.1016/0024-3205(71)90146-9. [DOI] [PubMed] [Google Scholar]
  2. Barbeau A., Mars H., Gillo-Joffroy L. Adverse clinical side effects of levodopa therapy. Contemp Neurol Ser. 1971;8:203–237. [PubMed] [Google Scholar]
  3. Bernheimer H., Birkmayer W., Hornykiewicz O. Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien Klin Wochenschr. 1966 Jun 10;78(23):417–419. [PubMed] [Google Scholar]
  4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  5. Birkmayer W. The importance of monoamine metabolism for the pathology of the extrapyramidal system. J Neurovisc Relat. 1969;31(Suppl):297+–297+. doi: 10.1007/978-3-662-25519-3_15. [DOI] [PubMed] [Google Scholar]
  6. Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
  7. Curzon G., Gumpert J., Sharpe D. Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):514–519. doi: 10.1136/jnnp.35.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guilleminault C., Tharp B. R., Cousin D. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements. J Neurol Sci. 1973 Apr;18(4):435–441. doi: 10.1016/0022-510x(73)90137-8. [DOI] [PubMed] [Google Scholar]
  9. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
  10. Klawans H. L., Jr A pharmacologic analysis of Huntington's chorea. Eur Neurol. 1970;4(3):148–163. doi: 10.1159/000114017. [DOI] [PubMed] [Google Scholar]
  11. Klawans H. L., Jr Cerebrospinal fluid homovanillic acid in Huntington's chorea. J Neurol Sci. 1971 Jul;13(3):277–279. doi: 10.1016/0022-510x(71)90032-3. [DOI] [PubMed] [Google Scholar]
  12. Klawans H. L., Jr, Garvin J. S. Treatment of parkinsonism with L-dopa (study of 105 patients). Dis Nerv Syst. 1969 Nov;30(11):737–746. [PubMed] [Google Scholar]
  13. Korf J., Ottema S., van der Veen I. Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. Anal Biochem. 1971 Mar;40(1):187–191. doi: 10.1016/0003-2697(71)90091-1. [DOI] [PubMed] [Google Scholar]
  14. Korf J., Valkenburgh-Sikkema T. Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. Clin Chim Acta. 1969 Nov;26(2):301–306. doi: 10.1016/0009-8981(69)90383-0. [DOI] [PubMed] [Google Scholar]
  15. Korf J., van Praag H. M., Sebens J. B. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol. 1971 Mar;20(3):659–668. doi: 10.1016/0006-2952(71)90152-3. [DOI] [PubMed] [Google Scholar]
  16. Lal S., De la Vega C., Garelis E., Sourkes T. L. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea. Psychiatr Neurol Neurochir. 1973 Mar-Apr;76(2):113–117. [PubMed] [Google Scholar]
  17. Marsden C. D. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). Mod Trends Neurol. 1975;6:141–166. [PubMed] [Google Scholar]
  18. Schenk G., Leijnse-Ybema H. J. Letter: Huntington's chorea and levodopa. Lancet. 1974 Mar 2;1(7853):364–364. doi: 10.1016/s0140-6736(74)93130-4. [DOI] [PubMed] [Google Scholar]
  19. Tan B. K., Leijnse-Ybema H. J., v d Brand H. J. Levodopa in Huntington's chorea. Lancet. 1972 Apr 22;1(7756):903–903. doi: 10.1016/s0140-6736(72)90773-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES